Prospects of chimeric antigen receptor T-Cell therapy in myelofibrosis: From immunopathogenesis to therapeutic strategies
Last Updated: Thursday, August 13, 2026
In a clinical review, researchers discuss potential CAR T-cell therapy targets in myelofibrosis. They highlight current translational challenges, such as on-target, off-tumor toxicity and impaired CAR-T persistence, and discuss emerging approaches.
Advertisement
News & Literature Highlights
